FDA inspection
Nanjing White Whale Pharmaceutical Co., Ltd.: FDA inspection ending Jan 25, 2024
FDA inspection 1228562 · Voluntary Action Indicated (VAI) · Nanjing
Key facts
| Inspection ID | 1228562 |
|---|---|
| Firm | Nanjing White Whale Pharmaceutical Co., Ltd. |
| FEI number | 3003821347 |
| Address | No. 29 Fangshuidonglu Road, Jiangbei New Area |
| City | Nanjing |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Jan 25, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| Product type | Veterinary |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data